International Journal of Clinical Pediatric Dentistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  17 (2024)
Volume  16 (2023)
Volume  15 (2022)
Volume  14 (2021)
Volume  13 (2020)
Volume  12 (2019)
Volume  11 (2018)
Volume  10 (2017)
Volume  9 (2016)
Volume  8 (2015)
Volume  7 (2014)
Volume  6 (2013)
Volume  5 (2012)
Volume  4 (2011)
Volume  3 (2010)
Volume  2 (2009)
Volume  1 (2008)
Related articles

VOLUME 17 , ISSUE S1 ( April, 2024 ) > List of Articles

ORIGINAL RESEARCH

To Evaluate and Compare Platelet-rich Fibrin and Mineral Trioxide Aggregate as Direct Pulp Capping Agents in Primary Molars: A Randomized Prospective Clinical Study

Tanu Tiwari, Parimala Tyagi, Shilpi Tiwari, Shikha Mali, Mydukur S Moudgalya, Nandani Jaiswal

Keywords : Children, Direct pulp capping, Mineral trioxide aggregate, Platelet-rich fibrin, Pulpotomy

Citation Information :

DOI: 10.5005/jp-journals-10005-2859

License: CC BY-NC 4.0

Published Online: 30-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim: This study aimed to evaluate and compare the clinical and radiographic success of platelet-rich fibrin (PRF) and mineral trioxide aggregate (MTA) as direct pulp capping (DPC) agents in primary molars. Materials and methods: In this study, 50 primary first and second molars from healthy children aged 5–9 years requiring pulp therapy were randomly allocated into two groups. In the PRF group, after coronal pulp removal and hemostasis, the remaining pulp tissue was covered with PRF preparation. In the MTA group, after coronal pulp removal and hemostasis, MTA was placed, followed by a zinc oxide eugenol (ZOE) base and glass ionomer cement (GIC) in both groups. Clinical and radiographic evaluations were undertaken at 1-, 3-, 6-, 9-, and 12-month intervals. Results: By the end of the 12th month, the overall success rate was 82.6% in the PRF group, whereas it was 61.9% in the MTA group. Conclusion: Platelet-rich fibrin can be used successfully as an appropriate alternative material in DPC of primary teeth when compared with MTA.

HTML PDF Share
  1. Hiremath H, Saikalyan S, Kulkarni SS, et al. Second-generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report. Int Endod J 2012;45(1):105–112. DOI: 10.1111/j.1365-2591.2011.01973.x
  2. Tronstad L, Mjor IA. Capping of the inflamed pulp. Oral Surg Oral Med Oral Pathol 1972;34(3):477–485. DOI: 10.1016/0030-4220(72)90327-1
  3. Barr ES, Flaitz CM, Hicks MJ. A retrospective radiographic evaluation of primary molar pulpectomies. Pediatr Dent 1991;13(1):4–9.
  4. Langeland K. Management of the inflamed pulp associated with deep carious lesion. J Endod 1981;7(4):169–181. DOI: 10.1016/S0099-2399(81)80231-2
  5. Bergenholtz G. Advances since the paper by Zander and Glass (1949) on the pursuit of healing methods for pulpal exposure: historical perspectives. Oral surgMed Oral Radiol Oral 2005:100(2 suppl):S102–S108. DOI: 10.1016/j.tripleo.2005.03.032
  6. Al-Hiyasat AS, Barrieshi Nusair KM, Al-Omari MA. The radiographic outcomes of direct pulp-capping procedures performed by dental students: a retrospective study. JADA 2006:137(12):1699–1705. DOI: 10.14219/jada.archive.2006.0116
  7. Kopel HM. Considerations for the direct pulp capping in primary teeth: a review of the literature. ASDC J Dent Child 1992;59(2):141–149.
  8. Bodem O, Blumenshine S, Zeh D, et al. Direct pulp capping with mineral trioxide aggregate in a primary molar: a case report. Int J Paediatr Dent 2004;14(5):346–379. DOI: 10.1111/j.1365-263X.2004.00547.x
  9. Moritz A, Schoop U, Goharkhav K, et al. The CO2 laser as an aid in direct pulp capping. J Endod 1998:24(4):248–251. DOI: 10.1016/S0099-2399(98)80106-4
  10. Goldberg M, Six N, Decup F, et al. Bioactive molecules and the future of pulp therapy. Am J Dent 2003:16(1):66–76.
  11. Dahnardt JE, Jaeggi T, Lussi A. Treating open carious lesions in anxious children with ozone: a prospective controlled clinical study. Am J Dent 2006:19(5):267–270.
  12. Hahn CL, Liewehr FR. Relationship between caries bacterial host responses, and clinical signs and symtoms of pulpitis. J Endod 2007;33(3):213–219. DOI: 10.1016/j.joen.2006.11.008
  13. Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review–part III: clinical applications, drawbacks, and mechanism of action. J Endod 2010;36(3):400–413. DOI: 10.1016/j.joen.2009.09.009
  14. Monterio Bramante C, Demachi AC, de Moraes IG, et al. Presence of arsenic in different types of MTA and white and gray Portland cement. J Endod 2008;106(6):909–913. DOI: 10.1016/j.tripleo.2008.07.018
  15. Choukroun J, Adda F, Vervelle A, et al. Une opportunit?? en paro-implantologie: le PRF. Implantodontie 2001;42:55–62.
  16. Mente J, Geletneky B, Ohle M, et al. Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod 2010;36(5):806–813. DOI: 10.1016/j.joen.2010.02.024
  17. Bogen G, Kim JS, Bakland LK. Direct pulp capping with mineral trioxide aggregate: an observational study. J Am Dent Assoc 2008:139(5):305–541. DOI: 10.14219/jada.archive.2008.0160
  18. Costa CA, Vaerten MA, Edwards CA, et al. Cytotoxic effects of current dental adhesive systems on immortalized odontoblast cell line MDPC-23. Dent Mater 1999;15(6):434–441. DOI: 10.1016/s0109-5641(99)00071-8
  19. Fuks AB. Vital pulp therapy with new materials for primary teeth: the directions and treatment perspectives. J Endod 2008;34(7 Suppl):S18–S24. DOI: 10.1016/j.joen.2008.02.031
  20. Omar AS, Meligy EL, Avery DR. Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis). Pediatr Dent 2006;28(5):399–404.
  21. Goodis HE, Kinaia BM, Kinaia AM, et al. Regenerative endodontics and tissue engineering: what the future holds? Dent Clin North Am 2012;56(3):677–689. DOI: 10.1016/j.cden.2012.05.007
  22. Kennedy D, Kapala J. The Dental Pulp: Biological Considerations of Protection and Treatment. Baltimore, United States of America: Williams & Wilkins; 1985. pp. 492–522.
  23. Cox CF, Subay RK, Ostro E, et al. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent 1996;21(1):4–11.
  24. Menezes R, Bramante CM, Letra A, et al. Histologic evaluation of pulpotomies in dog using two types of mineral trioxide aggregate and regular and white Portland cements as wound dressings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98(3):376–379. DOI: 10.1016/S107921040400215X
  25. Jabbarifar SE, Khademi AA, Ghasemi D. Success rate of formocresol pulpotomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004;6(6):55–98.
  26. Glass RL, Zander HA. Pulp healing. J Dent Res 1949;28(2):97–107. DOI: 10.1177/00220345490280021101
  27. Ford TR, Torabinejad M, Abedi HR, et al. Using mineral trioxide aggregate as a pulp-capping material. JADA 1996;127(10):1491–1494. DOI: 10.14219/jada.archive.1996.0058
  28. Caicedo R, Abbott PV, Alongi DJ, et al. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpothomies of primary teeth. Aust Dent J 2006;51(4):297–305. DOI: 10.1111/j.1834-7819.2006.tb00447.x
  29. Kotsanos N, Arapostathis KN, Arhakis A, et al. Direct pulp capping of carious primary molars. A specialty practice based study. J Clin Pediatr Dent 2014;38(4):307–312. DOI: 10.17796/jcpd.38.4.k651814611318430
  30. Asl Aminabadi N, Satrab S, Najafpour E, et al. A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. Int J Paediatr Dent 2016;26(4):281–290. DOI: 10.1111/ipd.12196
  31. Tuna D, Olmez A. Clinical long-term evaluation of MTA as a direct pulp capping material in primary teeth. Int Endod J 2008;41(4):273–278. DOI: 10.1111/j.1365-2591.2007.01339.x
  32. Fridland M, Rosado R. MTA solubility: a long-term study. J Endodo 2005;31(5):376–379. DOI: 10.1097/01.don.0000140566.97319.3e
  33. Torabinejad M, Parirokh M. Mineral trioxide aggregate: a comprehensive literature review—part II: leakage and biocompatibility investigations. J Endod 2010;36(2):190–202. DOI: 10.1016/j.joen.2009.09.010
  34. Shah N, Logani A, Bhaskar U, et al. Efficacy of revascularization to induce apexification/apexogensis in infected, nonvital, immature teeth: a pilot clinical study. J Endod 2008;34(8):919–925. DOI: 10.1016/j.joen.2008.05.001
  35. Kalaskar RR, Damle SG, Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in primary molars. J Indian Soc Pedod Prev Dent 2004;22(1):24–29.
  36. Barthel CR, Rosenkranz B, Leurenberg A, et al. Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study. J Endod 2000:26(9):525–528. DOI: 10.1097/00004770-200009000-00010
  37. Patidar S, Karla N, Khatri A, et al. Clinical and radiographic comparison of patelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars. J Indian Soc Pedod Prev Dent 2017;35(4):367–373. DOI: 10.4103/JISPPD.JISPPD_178_17
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.